Hybrid Course Assessment and Evaluation
Launched by RESEARCH ON HEALTHCARE PERFORMANCE LAB U1290 · May 7, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to teaching medical students in France, specifically those in postgraduate general practice training. As the number of students increases, there are not enough teaching hours available. To address this, the trial will compare two teaching methods: a hybrid model that combines online learning with in-person classes, and traditional face-to-face classes. The goal is to see which method better helps students learn and develop important problem-solving skills.
To participate in this trial, you must be a postgraduate general practice student who is officially registered for the assessed course. Participants will be randomly assigned to either the hybrid or traditional teaching group. Everyone involved can expect to contribute to important research that may improve future medical education. Please note that interested students need to provide signed consent to participate after receiving all necessary information about the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Postgraduate general practice students registered for assessed course.
- Exclusion Criteria:
- • • Unsigned written consent to participate after oral and written information
About Research On Healthcare Performance Lab U1290
The Research on Healthcare Performance Lab U1290 is a dedicated clinical trial sponsor focused on advancing healthcare outcomes through rigorous research and innovative methodologies. With a commitment to improving patient care, the lab conducts comprehensive studies that evaluate healthcare performance metrics, treatment efficacy, and patient satisfaction. By collaborating with healthcare institutions and leveraging cutting-edge technologies, U1290 aims to generate actionable insights that drive evidence-based practices and enhance the overall quality of care in diverse medical settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Rémy Boussageon, MD, PhD
Study Chair
Lyon 1 University & LBBE UMR 5558, CNRS
Marion Lamort-Bouché, MD, PhD
Study Director
Research on Healthcare Performance Lab U1290, Inserm
Pierre-Yves Meunier, MD
Principal Investigator
University Lyon 1
Sophie Schlatter, PhD
Study Chair
Research on Healthcare Performance Lab U1290, Inserm
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported